Intemittant, Continue, Oxytocin
Conditions
Brief summary
This study evaluates continuous oxytocin versus intermittent oxytocin for induction of labor at term. Half of participants will be taken continuous oxytocin, while the other half will be taken intermittent oxytocin.
Detailed description
In the continuous oxytocin group, traditional treatment of oxytocin used at a starting dose of 1-2 mIU/min and the dose was increased by 2 mIU/min at every 15 minutes until regular contractions obtained at a rate of 3-5 contractions in a 10-minute period. The maximum dose of oxytocin was 40 mIU/min and oxytocin was administered until delivery. In the intermittent group, oxytocin was discontinued when cervical dilation was 5 cm and 2 hours after discontinuation oxytocin was reused at a starting dose of 1-2 mIU/min and was increased as the same protocol used for continuation oxytocin group.
Interventions
DRUGOxytocin
Sponsors
Zeynep Kamil Maternity and Pediatric Research and Training Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes
Inclusion criteria
* singleton pregnancy, * 37≤ weeks of gestational age , * vertex presentation, * women with cervical dilation 3 cm * no contraindication to vaginal delivery.
Exclusion criteria
* fetal malpresentation, * multifetal pregnancy, * more than three contractions in 10 minutes, * contraindications to oxytocin, * a category II or III fetal heart rate pattern, * fetal anomaly, * fetal demise * women with immediate delivery indications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| induction-to-delivery time | intraoperative |
Countries
Turkey (Türkiye)
Contacts
Primary Contactevrim bostanci ergen, M.D.
Outcome results
None listed